Cargando…

Constitutive CCND1/CDK2 Activity Substitutes for p53 Loss, or MYC or Oncogenic RAS Expression in the Transformation of Human Mammary Epithelial Cells

Cancer develops following the accumulation of genetic and epigenetic alterations that inactivate tumor suppressor genes and activate proto-oncogenes. Dysregulated cyclin-dependent kinase (CDK) activity has oncogenic potential in breast cancer due to its ability to inactivate key tumor suppressor net...

Descripción completa

Detalles Bibliográficos
Autores principales:	Junk, Damian J., Cipriano, Rocky, Stampfer, Martha, Jackson, Mark W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563539/ https://www.ncbi.nlm.nih.gov/pubmed/23390492 http://dx.doi.org/10.1371/journal.pone.0053776

Ejemplares similares

Role of CCND1 and C-MYC oncogenes in metastatic breast cancer patients treated by herceptin
por: Trojanec, R, et al.
Publicado: (2011)

Molecular Analysis of Oncogenes, ras Family Genes (N‐ras, K‐ras, H‐ras), myc Family Genes (c‐myc, N‐myc) and mdm2 in Natural Killer Cell Neoplasms
por: Sugimoto, Kei‐ji, et al.
Publicado: (2002)

Regulation of Rb family proteins by Cdk6/Ccnd1 in growth plates
por: Komori, Toshihisa
Publicado: (2013)

Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.
por: Telang, N. T., et al.
Publicado: (1998)

Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas
por: Tran, Phuoc T., et al.
Publicado: (2008)

A Driver Never Works Alone—Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer
por: Grzes, Maria, et al.
Publicado: (2020)

Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer
por: Watters, A D, et al.
Publicado: (2002)

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
por: Stahl, Phillip, et al.
Publicado: (2015)

Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression.
por: Wyllie, A. H., et al.
Publicado: (1987)

Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability.
por: Arends, M. J., et al.
Publicado: (1993)

Oncogenic K-ras confers SAHA resistance by up-regulating HDAC6 and c-myc expression
por: Wang, Qun, et al.
Publicado: (2016)

ZEB1 and oncogenic Ras constitute a regulatory switch for stimulus‐dependent E‐cadherin downregulation
por: Otake, Shigeo, et al.
Publicado: (2020)

Double-Hit Primary Plasma Cell Leukemia with IGH/MYC and IGH/CCND1 Translocations
por: Yasumi, Masato, et al.
Publicado: (2020)

Analysis of the c‐myc, K‐ras and p53 Genes in Methylcholanthrene induced Mouse Sarcomas
por: Watanabe, Hiroshi, et al.
Publicado: (1999)

MiR-181a functions as an oncogene by regulating CCND1 in multiple myeloma
por: Yan, Xiao, et al.
Publicado: (2020)

A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis
por: Ozsvari, Bela, et al.
Publicado: (2017)

Oncogenic RAS promotes MYC protein stability by upregulating the expression of the inhibitor of apoptosis protein family member Survivin
por: Chang, Wen-Hsuan, et al.
Publicado: (2022)

Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation
por: Date, Yuki, et al.
Publicado: (2020)

Mantle cell lymphoma-like lymphomas in c-myc-3'RR/p53(+/−) mice and c-myc-3'RR/Cdk4(R24C) mice: differential oncogenic mechanisms but similar cellular origin
por: Rouaud, Pauline, et al.
Publicado: (2012)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.
por: Weston, A, et al.
Publicado: (1992)

DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1
por: Zhang, Haonan, et al.
Publicado: (2022)

K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc
por: Magudia, Kirti, et al.
Publicado: (2012)

Induction of non-apoptotic programmed cell death by oncogenic RAS in human epithelial cells and its suppression by MYC overexpression
por: Dendo, Kasumi, et al.
Publicado: (2018)

Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress
por: Maya-Mendoza, Apolinar, et al.
Publicado: (2014)

FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance
por: Bartel, Courtney A., et al.
Publicado: (2016)

CD5-negative Blastoid Variant Mantle Cell Lymphoma with Complex CCND1/IGH and MYC Aberrations
por: Seok, Yoonmi, et al.
Publicado: (2012)

CDK5: an oncogene or an anti-oncogene: location location location
por: Nikhil, Kumar, et al.
Publicado: (2023)

Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas
por: Xu, Jia, et al.
Publicado: (2018)

Downregulation of oncogenic RAS and c-Myc expression in MOLT-4 leukaemia cells by a salicylaldehyde semicarbazone copper(II) complex
por: Goh, Yan-Yih, et al.
Publicado: (2016)

Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence
por: Atwood, Allison A., et al.
Publicado: (2010)

A high-fat diet increases the incidence of mammary cancer inc-Ha-ras proto-oncogene transgenic rats
por: Magaki, Mie, et al.
Publicado: (2016)

Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53
por: Segeren, Hendrika A., et al.
Publicado: (2022)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

Oncogenic MYC amplifies mitotic perturbations
por: Littler, Samantha, et al.
Publicado: (2019)

Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
por: Augsten, Martin, et al.
Publicado: (2014)

A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency
por: Pecce, Valeria, et al.
Publicado: (2018)

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
por: Zeng, Mei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bvf2360t3akkf571pc3p9313fc